Brochure
4 Oct 2022

OXYCAPT Multilayer Plastic Vial

PDF 642 kB

OXYCAPT consists of three layers, Cyclo Olefin Polymer (COP)/ New polymer with excellent oxygen barrier/ COP. The oxygen barrier is more than 20 times better than existing COP containers and the amount of inorganic extractables are much lower than Type 1 Glass. We believe OXYCAPT multilayer plastic vial is more suitable for oxygen sensitive drugs like biologics and gene/cell therapies than glass.

Content provided by our supplier

Mitsubishi Gas Chemical Company Inc.

  • JP
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

Other Content from Mitsubishi Gas Chemical Company Inc. (2)

  • Webinar OXYCAPT Multilayer Plastic Vial for Biologics and Cell & Gene Therapies

    This session will explore: High Oxygen, CO2 and UV Barrier suitable for Biologics and Cell & Gene Therapies Extremely Low Inorganic Extractables Suitable for Biologics and Cell & Gene Therapies New Container Closure Integrity (CCI) Data at Deep Cold Storage (-80 degree C)
  • Webinar Latest Data of OXYCAPT Multilayer Plastic Vial

    OXYCAPT is a multilayer plastic vial that consists of three layers, COP/New Polyester/COP. The product has achieved excellent oxygen & ultraviolet (UV) light barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, lightweight, etc. For example, the oxygen barrier is about 20 times better than the COP monolayer vial and the UV barrier is much better than the transparent type-1 glass and COP monolayer vials. We will show a lot of new useful data such as ultra-low temperature resistance, quick defrosting test, photo-stability test on antibody drugs, etc. We believe that OXYCAPT can offer a multitude of benefits to the rapidly growing field of biologics and gene/cell therapies.